Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Obstetrical and Gynecological Survey

Volumn 64, Issue 12, 2009, Pages 805-807

  Cummings, Steven R ^a   Martin, Javier San ^a   McClung, Michael R ^a   Siris, Ethel S ^a   Eastell, Richard ^a   Reid, Ian R ^a   Delmas, Pierre ^a   Zoog, Holly B ^a   Austin, Matt ^a   Wang, Andrea ^a   Kutilek, Stepan ^a   Adami, Silvano ^a   Zanchetta, Jose ^a   Libanati, Cesar ^a   Siddhanti, Suresh ^a   Christiansen, Claus ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; PARATHYROID HORMONE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; ZOLEDRONIC ACID;

ADULT; AGED; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; FEMALE; FRACTURE; FRACTURE NONUNION; HAZARD RATIO; HIP; HIP FRACTURE; HUMAN; HYPOCALCEMIA; INJECTION SITE REACTION; JAW OSTEONECROSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; NOTE; OSTEOCLAST; OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; SPINE RADIOGRAPHY; TREATMENT OUTCOME; VERTEBRA FRACTURE;

EID: 73449109494     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/01.ogx.0000363236.41902.96     Document Type: Note

References (0)